SARS-CoV-2 Sequence Data Analysis Bid Number: 3000017641 Date Issued: 09/24/2021 Bid Open Date/Time: 10/04/2021 4:30:00 PM CT Original: https://wwwcfprd.doa.louisiana.gov/osp/lapac/agency/pdf/7714500.pdf
This is a powerful tool for performing microarray and next gen sequence data analysis to get biologically meaningful functional information. Finally, this is a recognized brand name tool that is in high demand across the NIH campus.
Bacterial whole genome sequence data analysis including pathogen classification, antimicrobial resistance genes, and genetic clusters.
Fast access to sequence data immediately following sequencing and analysis by LIMS or similar system is required.Evaluation Factors: Technical Approach, Past Performance, and price. Evaluation Factors other than price, when combined, are significantly more important than price.Two days added for vendor response.Questions and Answers:Please advise if the “tissue fixation” process is to be provided by the Navy Lab, or by the supplier.
Geological Survey Survey intends to award a non-competitive contract in accordance with FAR Subpart 13.5 Simplified Procedures for Certain Commercial Items, for access to a cloud-based software and databases for analysis of raw DNA/RNA sequence data that includes raw sequence data processing (QC, pair end alignment, etc.) and variety of bioinformatic analyses.
G17PS00441 Solicitation for DNA Analysis of Non-human (Brook Trout) DNAThe US Geological Survey requires the analysis DNA to generate genetic sequence data for brook trout for a long-term study. Work is to be performed on each brook trout tissue sample following standard protocols including DNA extraction and quantification, restriction site associated DNA sequencing library preparation, and sequencing on an Illumina HiSeq 4000.
This service shall include pre-validated NGS capture kits to generate Exome sequence librairies and provide comprehensive data analysis, variant calling, and recommend variant classification for multigene and Exome NGS panel analysis. Period of Performance will be 12 September 2022 - 13 September 2023, plus four one-year option periods.
